175 related articles for article (PubMed ID: 22791943)
1. Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors.
Guo AT; Li YM; Wei LX
World J Gastroenterol; 2012 Jun; 18(24):3081-8. PubMed ID: 22791943
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
Lu YY; Guo AT; Liu AJ; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
[TBL] [Abstract][Full Text] [Related]
3. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
Ronnett BM; Zahn CM; Kurman RJ; Kass ME; Sugarbaker PH; Shmookler BM
Am J Surg Pathol; 1995 Dec; 19(12):1390-408. PubMed ID: 7503361
[TBL] [Abstract][Full Text] [Related]
4. [Histologic classification and prognostic implication of pseudomyxoma peritonei].
Guo AT; Wei LX; Song X
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):474-9. PubMed ID: 17845762
[TBL] [Abstract][Full Text] [Related]
5. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
[TBL] [Abstract][Full Text] [Related]
6. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.
Bradley RF; Stewart JH; Russell GB; Levine EA; Geisinger KR
Am J Surg Pathol; 2006 May; 30(5):551-9. PubMed ID: 16699309
[TBL] [Abstract][Full Text] [Related]
7. Significance of epithelial cell clusters in pseudomyxoma peritonei.
Badyal RK; Khairwa A; Rajwanshi A; Nijhawan R; Radhika S; Gupta N; Dey P
Cytopathology; 2016 Dec; 27(6):418-426. PubMed ID: 27121698
[TBL] [Abstract][Full Text] [Related]
8. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
9. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
Ronnett BM; Seidman JD
Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249
[TBL] [Abstract][Full Text] [Related]
10. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.
Jackson SL; Fleming RA; Loggie BW; Geisinger KR
Mod Pathol; 2001 Jul; 14(7):664-71. PubMed ID: 11454998
[TBL] [Abstract][Full Text] [Related]
11. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
[TBL] [Abstract][Full Text] [Related]
12. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification.
Pai RK; Longacre TA
Adv Anat Pathol; 2005 Nov; 12(6):291-311. PubMed ID: 16330927
[TBL] [Abstract][Full Text] [Related]
13. COX-2 expression in pseudomyxoma peritonei.
Gatalica Z; Loggie B
Cancer Lett; 2006 Nov; 244(1):86-90. PubMed ID: 16427185
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases.
Morera Ocón FJ; Camps Vilata B; Muñoz Forner E; Navarro Campoy C; Gallego Plazas J; Navarro Fos S
Med Clin (Barc); 2017 Aug; 149(4):153-156. PubMed ID: 28549831
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of single isolated cells with decreased E-cadherin expression in pseudomyxoma peritonei.
Koh YW; Jun SY; Kim KR
Pathol Int; 2014 Apr; 64(4):164-72. PubMed ID: 24750186
[TBL] [Abstract][Full Text] [Related]
16. [Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification].
Reu S; Neumann J; Kirchner T
Pathologe; 2012 Feb; 33(1):24-30. PubMed ID: 22179200
[TBL] [Abstract][Full Text] [Related]
17. Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis.
Masckauchan D; Trabulsi N; Dubé P; Aubé-Lecompte ME; Cloutier AS; Mitchell A; Sideris L
Surg Oncol; 2019 Mar; 28():69-75. PubMed ID: 30851915
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of primary epithelial appendiceal neoplasms.
Gupta S; Parsa V; Adsay V; Heilbrun LK; Smith D; Shields AF; Weaver D; Philip PA; El-Rayes BF
Med Oncol; 2010 Dec; 27(4):1073-8. PubMed ID: 19851895
[TBL] [Abstract][Full Text] [Related]
19. The value of grading dysplasia in appendiceal mucinous neoplasm in the absence of pseudomyxoma peritonei.
Singhal S; Giner-Segura F; Barnes TG; Hompes R; Guy R; Wang LM
Histopathology; 2018 Aug; 73(2):351-354. PubMed ID: 29572977
[No Abstract] [Full Text] [Related]
20. Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.
van Eden WJ; Kok NFM; Snaebjornsson P; Jóźwiak K; Woensdregt K; Bottenberg PD; Boot H; Aalbers AGJ
BJS Open; 2019 Jun; 3(3):376-386. PubMed ID: 31183454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
